NCT06197386 Reliability and Validity of the Athlete Fear Avoidance Questionnaire in Turkish
| NCT ID | NCT06197386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atılım University |
| Condition | Athletic Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-07-31 |
| Primary Completion | 2024-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-07-31 with a primary completion date of 2024-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
High levels of fear avoidance can lead to chronic pain and disability and can predict rehabilitation time in the sports-related injury population. Therefore, taking fear avoidance into account may be useful in creating the most appropriate and effective rehabilitation plan, thus shortening the time to return to play. The aim of our study is to verify the validity and reliability of the Athlete Fear Avoidance Questionnaire (AFAQ) in Turkish.
Eligibility Criteria
Inclusion Criteria: * Being a licensed athlete for at least 5 years, being active in sports and training for the last 1 year, and weekly training intensity of at least 5 hours per week. Exclusion Criteria: * It was defined as having a history of visual, mental or systemic disease.
Contact & Investigator
Naime Uluğ, PhD.
PRINCIPAL INVESTIGATOR
ATILIM UNİVERSİTY
Frequently Asked Questions
Who can join the NCT06197386 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 19 Years, studying Athletic Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06197386 currently recruiting?
Yes, NCT06197386 is actively recruiting participants. Contact the research team at naime.ulug@atilim.edu.tr for enrollment information.
Where is the NCT06197386 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06197386 clinical trial?
NCT06197386 is sponsored by Atılım University. The principal investigator is Naime Uluğ, PhD. at ATILIM UNİVERSİTY. The trial plans to enroll 100 participants.